In Vitro Diagnostics (IVD) Market
In Vitro Diagnostics Market Overview
The report is titled as ‘In Vitro Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the In Vitro Diagnostics market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. In Vitro Diagnostics market is expected to grow with significant rate in the near future.
The global In Vitro Diagnostics (IVD) market in 2020 is estimated for more than US$ 70,561.9 Mn and expected to reach a value of US$ 1,03,310.9 Mn by 2028 with a significant CAGR of 4.9%.
In Vitro Diagnostics Market Dynamics
In-vitro diagnostics are tests performed in laboratories on biological samples such as blood, urine, tissue, etc. In vitro diagnostic are not only used for diagnosis but also provides useful information on monitoring of disease and treatment. Two-thirds of today’s clinical diagnoses involve in vitro diagnostics, hence are referred to as the backbone of healthcare.
In-vitro diagnostics market has witnessed substantial growth in last decade owing to technological advancements in testing methods as well as in analyzer instruments. According to the EPRS report, there are over 40,000 different IVD products available in the European market and per capita annual spending on IVD is approximately US$ 26. In-vitro diagnostics help to reduce the healthcare cost by making treatments more efficient and precise.
Evolving regulations for in-vitro diagnostics is the major driving force for market growth over the forecast period. For instance, regulation of medical devices in the European Union (EU) is undergoing a significant transformation with expanding the scope for in vitro diagnostics, which is expected to impact the increased product approvals for IVD in the region. Significant progress in point-of-care testing is another factor driving the growth of the global in-vitro diagnostics market. Introduction of molecular based assays and identification of range of biomarkers has opened up huge new opportunity for growth of global in-vitro diagnostics market.
In Vitro Diagnostics Market Competitive Landscape
Global market for in vitro diagnostics is dominated by Abbott Laboratories, Merck KGaG, F. Hoffman-La Roche AG, Becton Dickinson & Company, Danaher Corporation, Thermo Fisher Scientific Inc., Qiagen N.V., Diasorin S.P.A., biomerieux SA, Alere Inc., Bayer AG, Bio-Rad Laboratories Inc., Sysmex Corporation, etc. to name a few.
In Vitro Diagnostics Market Segmentation
The global in vitro diagnostics market is segmented on the basis of product type, technology, end user and region. On the basis of product type, in vitro diagnostics market is segmented as reagents and kits, analyze, and consumables. Based on technology, global market is segmented as immunochemistry, molecular diagnostics, hematology, point-of-care diagnostics, tissue diagnostics and clinical chemistry. On the basis of end user, global in vitro diagnostics market is segmented into hospitals, diagnostic centers, clinics, home care settings and others.
By Products & Services
• Reagents & Kits
• Instruments
o Fully Automated Instruments
o Semi-Automated Instruments
o Other Instruments
• Data Management Software
• Services
By Technology
• Immunoassay/Immunochemistry
o Enzyme-Linked Immunosorbent Assay
Chemiluminescence Immunoassays
Fluorescence Immunoassays
Colorimetric Immunoassays
o Radioimmunoassay
o Rapid Test
o Western Blotting
o Enzyme-Linked Immunospot Assays
• Clinical Chemistry
o Basic Metabolic Panel
o Electrolyte Panel
o Liver Panel
o Lipid Profile
o Renal Profile
o Thyroid Function Panel
o Specialty Chemical Tests
o Molecular Diagnostics
o Polymerase Chain Reaction
o Isothermal Nucleic Acid Amplification Technology
o Microarray
o Hybridization
o DNA Sequencing & Next-Generation Sequencing
o Other Mdx Technologies
• Microbiology
• Hematology
• Coagulation and Hemostasis
• Urinalysis
• Other IVD Technologies
By Application
• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Autoimmune Diseases
• Nephrology
• Drug Testing/Pharmacogenomics
• HIV/Aids
• Other Applications
By End User
• Hospitals
• Laboratories
o Large/Reference Laboratories
o Medium-Sized Laboratories
o Small Laboratories
• Point-Of-Care Testing
• Patient Self-Testing
• Academic Institutes
• Other End Users
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
In Vitro Diagnostics Market Regional Segmentation
On the basis of region, the global in vitro diagnostics market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America in vitro diagnostics market is expected to be the most dominating market throughout the forecast period due to growing number of product approvals. Presence of key players in Europe makes it second largest market for in vitro diagnostics.
Asia Pacific in vitro diagnostics market is expected to witness highest growth rate due to increasing number local players in China and India. In terms revenue in 2018, North America is accounted to hold more than 40% of the market share, owing to favorable government regulations and presence of the key players in the region, also advancement in technology and advanced healthcare infrastructure also lead to the growth of In vitro diagnostic market in this region.
MMC Overview on In Vitro Diagnostics Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the In Vitro Diagnostics market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of In Vitro Diagnostics
Advantages of In Vitro Diagnostics
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global In Vitro Diagnostic Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global In Vitro Diagnostic Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global In Vitro Diagnostic Market Snapshot
2.4. Global In Vitro Diagnostic Market Size and Forecast, 2019–2027
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)
2.5. Global In Vitro Diagnostic Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global In Vitro Diagnostic Market, By Product & Services
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Product & Services
3.1.2. BPS Analysis, By Product & Services
3.2. Market Revenue (US$Mn) Forecast, By Product & Services
3.2.1. Reagents & Kits
3.2.2. Instruments
3.2.2.1. Fully Automated Instruments
3.2.2.2. Semi-Automated Instruments
3.2.2.3. Other Instruments
3.2.3. Data Management Software
3.2.4. Services
3.3. Global In Vitro Diagnostic Market Attractiveness Index, By Product & Services
4. Global In Vitro Diagnostic Market, By Technology
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Technology
4.1.2. BPS Analysis, By Technology
4.2. Market Revenue (US$Mn) Forecast, By Technology
4.2.1. Immunoassay/Immunochemistry
4.2.1.1. Enzyme-Linked Immunosorbent Assay
4.2.1.1.1. Chemiluminescence Immunoassays
4.2.1.1.2. Fluorescence Immunoassays
4.2.1.1.3. Colorimetric Immunoassays
4.2.1.2. Radioimmunoassay
4.2.1.3. Rapid Test
4.2.1.4. Western Blotting
4.2.1.5. Enzyme-Linked Immunospot Assays
4.2.2. Clinical Chemistry
4.2.2.1. Basic Metabolic Panel
4.2.2.2. Electrolyte Panel
4.2.2.3. Liver Panel
4.2.2.4. Lipid Profile
4.2.2.5. Renal Profile
4.2.2.6. Thyroid Function Panel
4.2.2.7. Specialty Chemical Tests
4.2.2.8. Molecular Diagnostics
4.2.2.9. Polymerase Chain Reaction
4.2.2.10. Isothermal Nucleic Acid Amplification Technology
4.2.2.11. Microarray
4.2.2.12. Hybridization
4.2.2.13. DNA Sequencing & Next-Generation Sequencing
4.2.2.14. Other Mdx Technologies
4.2.3. Microbiology
4.2.4. Hematology
4.2.5. Coagulation and Haemostasis
4.2.6. Urinalysis
4.2.7. Other IVD Technologies
4.3. Global In Vitro Diagnostic Market Attractiveness Index, By Technology
5. Global In Vitro Diagnostic Market, By Application
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Application
5.1.2. BPS Analysis, By Application
5.2. Market Revenue (US$Mn) Forecast, By Application
5.2.1. Infectious Diseases
5.2.2. Diabetes
5.2.3. Oncology
5.2.4. Cardiology
5.2.5. Autoimmune Diseases
5.2.6. Nephrology
5.2.7. Drug Testing/Pharmacogenomics
5.2.8. HIV/Aids
5.2.9. Other Applications
5.3. Global In Vitro Diagnostic Market Attractiveness Index, By Application
6. Global In Vitro Diagnostic Market, By End User
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By End User
6.1.2. BPS Analysis, By End User
6.2. Market Revenue (US$Mn) Forecast, By End User
6.2.1. Hospitals
6.2.2. Laboratories
6.2.2.1. Large/Reference Laboratories
6.2.2.2. Medium-Sized Laboratories
6.2.2.3. Small Laboratories
6.2.3. Point-Of-Care Testing
6.2.4. Patient Self-Testing
6.2.5. Academic Institutes
6.2.6. Other End Users
6.3. Global In Vitro Diagnostic Market Attractiveness Index, By End User
7. Global In Vitro Diagnostic Market, By Region
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Region
7.1.2. BPS Analysis, By Region
7.2. Market Revenue (US$Mn) Forecast, By Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Europe
7.2.4. Asia Pacific
7.2.5. Middle East
7.2.6. Africa
7.3. Global In Vitro Diagnostic Market Attractiveness Index, By Region
8. North America In Vitro Diagnostic Market Analysis and Forecast, 2019–2027
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$Mn) Forecast, By Country
8.2.1. U.S. In Vitro Diagnostic Market
8.2.2. Canada In Vitro Diagnostic Market
8.3. North America In Vitro Diagnostic Market, By Product & Services
8.3.1. Reagents & Kits
8.3.2. Instruments
8.3.2.1. Fully Automated Instruments
8.3.2.2. Semi-Automated Instruments
8.3.2.3. Other Instruments
8.3.3. Data Management Software
8.3.4. Services
8.4. North America In Vitro Diagnostic Market, By Technology
8.4.1. Immunoassay/Immunochemistry
8.4.1.1. Enzyme-Linked Immunosorbent Assay
8.4.1.1.1. Chemiluminescence Immunoassays
8.4.1.1.2. Fluorescence Immunoassays
8.4.1.1.3. Colorimetric Immunoassays
8.4.1.2. Radioimmunoassay
8.4.1.3. Rapid Test
8.4.1.4. Western Blotting
8.4.1.5. Enzyme-Linked Immunospot Assays
8.4.2. Clinical Chemistry
8.4.2.1. Basic Metabolic Panel
8.4.2.2. Electrolyte Panel
8.4.2.3. Liver Panel
8.4.2.4. Lipid Profile
8.4.2.5. Renal Profile
8.4.2.6. Thyroid Function Panel
8.4.2.7. Specialty Chemical Tests
8.4.2.8. Molecular Diagnostics
8.4.2.9. Polymerase Chain Reaction
8.4.2.10. Isothermal Nucleic Acid Amplification Technology
8.4.2.11. Microarray
8.4.2.12. Hybridization
8.4.2.13. DNA Sequencing & Next-Generation Sequencing
8.4.2.14. Other Mdx Technologies
8.4.3. Microbiology
8.4.4. Hematology
8.4.5. Coagulation and Haemostasis
8.4.6. Urinalysis
8.4.7. Other IVD Technologies
8.5. North America In Vitro Diagnostic Market, By Application
8.5.1. Infectious Diseases
8.5.2. Diabetes
8.5.3. Oncology
8.5.4. Cardiology
8.5.5. Autoimmune Diseases
8.5.6. Nephrology
8.5.7. Drug Testing/Pharmacogenomics
8.5.8. HIV/Aids
8.5.9. Other Applications
8.6. North America In Vitro Diagnostic Market, By End User
8.6.1. Hospitals
8.6.2. Laboratories
8.6.2.1. Large/Reference Laboratories
8.6.2.2. Medium-Sized Laboratories
8.6.2.3. Small Laboratories
8.6.3. Point-Of-Care Testing
8.6.4. Patient Self-Testing
8.6.5. Academic Institutes
8.6.6. Other End Users
8.7. North America In Vitro Diagnostic Market Attractiveness Index
8.7.1. By Country
8.7.2. By Product & Services
8.7.3. By Technology
8.7.4. By Application
8.7.5. By End User
9. Latin America In Vitro Diagnostic Market Analysis and Forecast, 2019–2027
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. Brazil In Vitro Diagnostic Market
9.2.2. Mexico In Vitro Diagnostic Market
9.2.3. Argentina In Vitro Diagnostic Market
9.2.4. Rest of Latin America In Vitro Diagnostic Market
9.3. Latin America In Vitro Diagnostic Market, By Product & Services
9.3.1. Reagents & Kits
9.3.2. Instruments
9.3.2.1. Fully Automated Instruments
9.3.2.2. Semi-Automated Instruments
9.3.2.3. Other Instruments
9.3.3. Data Management Software
9.3.4. Services
9.4. Latin America In Vitro Diagnostic Market, By Technology
9.4.1. Immunoassay/Immunochemistry
9.4.1.1. Enzyme-Linked Immunosorbent Assay
9.4.1.1.1. Chemiluminescence Immunoassays
9.4.1.1.2. Fluorescence Immunoassays
9.4.1.1.3. Colorimetric Immunoassays
9.4.1.2. Radioimmunoassay
9.4.1.3. Rapid Test
9.4.1.4. Western Blotting
9.4.1.5. Enzyme-Linked Immunospot Assays
9.4.2. Clinical Chemistry
9.4.2.1. Basic Metabolic Panel
9.4.2.2. Electrolyte Panel
9.4.2.3. Liver Panel
9.4.2.4. Lipid Profile
9.4.2.5. Renal Profile
9.4.2.6. Thyroid Function Panel
9.4.2.7. Specialty Chemical Tests
9.4.2.8. Molecular Diagnostics
9.4.2.9. Polymerase Chain Reaction
9.4.2.10. Isothermal Nucleic Acid Amplification Technology
9.4.2.11. Microarray
9.4.2.12. Hybridization
9.4.2.13. DNA Sequencing & Next-Generation Sequencing
9.4.2.14. Other Mdx Technologies
9.4.3. Microbiology
9.4.4. Hematology
9.4.5. Coagulation and Haemostasis
9.4.6. Urinalysis
9.4.7. Other IVD Technologies
9.5. Latin America In Vitro Diagnostic Market, By Application
9.5.1. Infectious Diseases
9.5.2. Diabetes
9.5.3. Oncology
9.5.4. Cardiology
9.5.5. Autoimmune Diseases
9.5.6. Nephrology
9.5.7. Drug Testing/Pharmacogenomics
9.5.8. HIV/Aids
9.5.9. Other Applications
9.6. Latin America In Vitro Diagnostic Market, By End User
9.6.1. Hospitals
9.6.2. Laboratories
9.6.2.1. Large/Reference Laboratories
9.6.2.2. Medium-Sized Laboratories
9.6.2.3. Small Laboratories
9.6.3. Point-Of-Care Testing
9.6.4. Patient Self-Testing
9.6.5. Academic Institutes
9.6.6. Other End Users
9.7. Latin America In Vitro Diagnostic Market Attractiveness Index
9.7.1. By Country
9.7.2. By Product & Services
9.7.3. By Technology
9.7.4. By Application
9.7.5. By End User
10. Europe In Vitro Diagnostic Market Analysis and Forecast, 2019–2027
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. U.K. In Vitro Diagnostic Market
10.2.2. Germany In Vitro Diagnostic Market
10.2.3. Italy In Vitro Diagnostic Market
10.2.4. France In Vitro Diagnostic Market
10.2.5. Spain In Vitro Diagnostic Market
10.2.6. Russia In Vitro Diagnostic Market
10.2.7. Poland In Vitro Diagnostic Market
10.2.8. BENELUX In Vitro Diagnostic Market
10.2.9. NORDIC In Vitro Diagnostic Market
10.2.10. Rest of Europe In Vitro Diagnostic Market
10.3. Europe In Vitro Diagnostic Market, By Product & Services
10.3.1. Reagents & Kits
10.3.2. Instruments
10.3.2.1. Fully Automated Instruments
10.3.2.2. Semi-Automated Instruments
10.3.2.3. Other Instruments
10.3.3. Data Management Software
10.3.4. Services
10.4. Europe In Vitro Diagnostic Market, By Technology
10.4.1. Immunoassay/Immunochemistry
10.4.1.1. Enzyme-Linked Immunosorbent Assay
10.4.1.1.1. Chemiluminescence Immunoassays
10.4.1.1.2. Fluorescence Immunoassays
10.4.1.1.3. Colorimetric Immunoassays
10.4.1.2. Radioimmunoassay
10.4.1.3. Rapid Test
10.4.1.4. Western Blotting
10.4.1.5. Enzyme-Linked Immunospot Assays
10.4.2. Clinical Chemistry
10.4.2.1. Basic Metabolic Panel
10.4.2.2. Electrolyte Panel
10.4.2.3. Liver Panel
10.4.2.4. Lipid Profile
10.4.2.5. Renal Profile
10.4.2.6. Thyroid Function Panel
10.4.2.7. Specialty Chemical Tests
10.4.2.8. Molecular Diagnostics
10.4.2.9. Polymerase Chain Reaction
10.4.2.10. Isothermal Nucleic Acid Amplification Technology
10.4.2.11. Microarray
10.4.2.12. Hybridization
10.4.2.13. DNA Sequencing & Next-Generation Sequencing
10.4.2.14. Other Mdx Technologies
10.4.3. Microbiology
10.4.4. Hematology
10.4.5. Coagulation and Haemostasis
10.4.6. Urinalysis
10.4.7. Other IVD Technologies
10.5. Europe In Vitro Diagnostic Market, By Application
10.5.1. Infectious Diseases
10.5.2. Diabetes
10.5.3. Oncology
10.5.4. Cardiology
10.5.5. Autoimmune Diseases
10.5.6. Nephrology
10.5.7. Drug Testing/Pharmacogenomics
10.5.8. HIV/Aids
10.5.9. Other Applications
10.6. Europe In Vitro Diagnostic Market, By End User
10.6.1. Hospitals
10.6.2. Laboratories
10.6.2.1. Large/Reference Laboratories
10.6.2.2. Medium-Sized Laboratories
10.6.2.3. Small Laboratories
10.6.3. Point-Of-Care Testing
10.6.4. Patient Self-Testing
10.6.5. Academic Institutes
10.6.6. Other End Users
10.7. Europe In Vitro Diagnostic Market Attractiveness Index
10.7.1. By Country
10.7.2. By Product & Services
10.7.3. By Technology
10.7.4. By Application
10.7.5. By End User
11. Asia Pacific In Vitro Diagnostic Market Analysis and Forecast, 2019–2027
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. China In Vitro Diagnostic Market
11.2.2. India In Vitro Diagnostic Market
11.2.3. Japan In Vitro Diagnostic Market
11.2.4. Australia and New Zealand In Vitro Diagnostic Market
11.2.5. South Korea In Vitro Diagnostic Market
11.2.6. ASEAN In Vitro Diagnostic Market
11.2.7. Rest of Asia Pacific In Vitro Diagnostic Market
11.3. Asia Pacific In Vitro Diagnostic Market, By Product & Services
11.3.1. Reagents & Kits
11.3.2. Instruments
11.3.2.1. Fully Automated Instruments
11.3.2.2. Semi-Automated Instruments
11.3.2.3. Other Instruments
11.3.3. Data Management Software
11.3.4. Services
11.4. Asia Pacific In Vitro Diagnostic Market, By Technology
11.4.1. Immunoassay/Immunochemistry
11.4.1.1. Enzyme-Linked Immunosorbent Assay
11.4.1.1.1. Chemiluminescence Immunoassays
11.4.1.1.2. Fluorescence Immunoassays
11.4.1.1.3. Colorimetric Immunoassays
11.4.1.2. Radioimmunoassay
11.4.1.3. Rapid Test
11.4.1.4. Western Blotting
11.4.1.5. Enzyme-Linked Immunospot Assays
11.4.2. Clinical Chemistry
11.4.2.1. Basic Metabolic Panel
11.4.2.2. Electrolyte Panel
11.4.2.3. Liver Panel
11.4.2.4. Lipid Profile
11.4.2.5. Renal Profile
11.4.2.6. Thyroid Function Panel
11.4.2.7. Specialty Chemical Tests
11.4.2.8. Molecular Diagnostics
11.4.2.9. Polymerase Chain Reaction
11.4.2.10. Isothermal Nucleic Acid Amplification Technology
11.4.2.11. Microarray
11.4.2.12. Hybridization
11.4.2.13. DNA Sequencing & Next-Generation Sequencing
11.4.2.14. Other Mdx Technologies
11.4.3. Microbiology
11.4.4. Hematology
11.4.5. Coagulation and Haemostasis
11.4.6. Urinalysis
11.4.7. Other IVD Technologies
11.5. Asia Pacific In Vitro Diagnostic Market, By Application
11.5.1. Infectious Diseases
11.5.2. Diabetes
11.5.3. Oncology
11.5.4. Cardiology
11.5.5. Autoimmune Diseases
11.5.6. Nephrology
11.5.7. Drug Testing/Pharmacogenomics
11.5.8. HIV/Aids
11.5.9. Other Applications
11.6. Asia Pacific In Vitro Diagnostic Market, By End User
11.6.1. Hospitals
11.6.2. Laboratories
11.6.2.1. Large/Reference Laboratories
11.6.2.2. Medium-Sized Laboratories
11.6.2.3. Small Laboratories
11.6.3. Point-Of-Care Testing
11.6.4. Patient Self-Testing
11.6.5. Academic Institutes
11.6.6. Other End Users
11.7. Asia Pacific In Vitro Diagnostic Market Attractiveness Index
11.7.1. By Country
11.7.2. By Product & Services
11.7.3. By Technology
11.7.4. By Application
11.7.5. By End User
12. Middle East In Vitro Diagnostic Market Analysis and Forecast, 2019–2027
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. GCC Countries In Vitro Diagnostic Market
12.2.2. Israel In Vitro Diagnostic Market
12.2.3. Oman In Vitro Diagnostic Market
12.2.4. Rest of Middle East In Vitro Diagnostic Market
12.3. Middle East In Vitro Diagnostic Market, By Product & Services
12.3.1. Reagents & Kits
12.3.2. Instruments
12.3.2.1. Fully Automated Instruments
12.3.2.2. Semi-Automated Instruments
12.3.2.3. Other Instruments
12.3.3. Data Management Software
12.3.4. Services
12.4. Middle East In Vitro Diagnostic Market, By Technology
12.4.1. Immunoassay/Immunochemistry
12.4.1.1. Enzyme-Linked Immunosorbent Assay
12.4.1.1.1. Chemiluminescence Immunoassays
12.4.1.1.2. Fluorescence Immunoassays
12.4.1.1.3. Colorimetric Immunoassays
12.4.1.2. Radioimmunoassay
12.4.1.3. Rapid Test
12.4.1.4. Western Blotting
12.4.1.5. Enzyme-Linked Immunospot Assays
12.4.2. Clinical Chemistry
12.4.2.1. Basic Metabolic Panel
12.4.2.2. Electrolyte Panel
12.4.2.3. Liver Panel
12.4.2.4. Lipid Profile
12.4.2.5. Renal Profile
12.4.2.6. Thyroid Function Panel
12.4.2.7. Specialty Chemical Tests
12.4.2.8. Molecular Diagnostics
12.4.2.9. Polymerase Chain Reaction
12.4.2.10. Isothermal Nucleic Acid Amplification Technology
12.4.2.11. Microarray
12.4.2.12. Hybridization
12.4.2.13. DNA Sequencing & Next-Generation Sequencing
12.4.2.14. Other Mdx Technologies
12.4.3. Microbiology
12.4.4. Hematology
12.4.5. Coagulation and Haemostasis
12.4.6. Urinalysis
12.4.7. Other IVD Technologies
12.5. Middle East In Vitro Diagnostic Market, By Application
12.5.1. Infectious Diseases
12.5.2. Diabetes
12.5.3. Oncology
12.5.4. Cardiology
12.5.5. Autoimmune Diseases
12.5.6. Nephrology
12.5.7. Drug Testing/Pharmacogenomics
12.5.8. HIV/Aids
12.5.9. Other Applications
12.6. Middle East In Vitro Diagnostic Market, By End User
12.6.1. Hospitals
12.6.2. Laboratories
12.6.2.1. Large/Reference Laboratories
12.6.2.2. Medium-Sized Laboratories
12.6.2.3. Small Laboratories
12.6.3. Point-Of-Care Testing
12.6.4. Patient Self-Testing
12.6.5. Academic Institutes
12.6.6. Other End Users
12.7. Middle East In Vitro Diagnostic Market Attractiveness Index
12.7.1. By Country
12.7.2. By Product & Services
12.7.3. By Technology
12.7.4. By Application
12.7.5. By End User
13. Africa In Vitro Diagnostic Market Analysis and Forecast, 2019–2027
13.1. Introduction
13.1.1. Annual Growth Rate Comparison, By Country
13.1.2. BPS Analysis, By Country
13.2. Market (US$Mn) Forecast, By Country
13.2.1. South Africa In Vitro Diagnostic Market
13.2.2. Egypt In Vitro Diagnostic Market
13.2.3. North Africa In Vitro Diagnostic Market
13.2.4. Rest of Africa In Vitro Diagnostic Market
13.3. Africa In Vitro Diagnostic Market, By Product & Services
13.3.1. Reagents & Kits
13.3.2. Instruments
13.3.2.1. Fully Automated Instruments
13.3.2.2. Semi-Automated Instruments
13.3.2.3. Other Instruments
13.3.3. Data Management Software
13.3.4. Services
13.4. Africa In Vitro Diagnostic Market, By Technology
13.4.1. Immunoassay/Immunochemistry
13.4.1.1. Enzyme-Linked Immunosorbent Assay
13.4.1.1.1. Chemiluminescence Immunoassays
13.4.1.1.2. Fluorescence Immunoassays
13.4.1.1.3. Colorimetric Immunoassays
13.4.1.2. Radioimmunoassay
13.4.1.3. Rapid Test
13.4.1.4. Western Blotting
13.4.1.5. Enzyme-Linked Immunospot Assays
13.4.2. Clinical Chemistry
13.4.2.1. Basic Metabolic Panel
13.4.2.2. Electrolyte Panel
13.4.2.3. Liver Panel
13.4.2.4. Lipid Profile
13.4.2.5. Renal Profile
13.4.2.6. Thyroid Function Panel
13.4.2.7. Specialty Chemical Tests
13.4.2.8. Molecular Diagnostics
13.4.2.9. Polymerase Chain Reaction
13.4.2.10. Isothermal Nucleic Acid Amplification Technology
13.4.2.11. Microarray
13.4.2.12. Hybridization
13.4.2.13. DNA Sequencing & Next-Generation Sequencing
13.4.2.14. Other Mdx Technologies
13.4.3. Microbiology
13.4.4. Hematology
13.4.5. Coagulation and Haemostasis
13.4.6. Urinalysis
13.4.7. Other IVD Technologies
13.5. Africa In Vitro Diagnostic Market, By Application
13.5.1. Infectious Diseases
13.5.2. Diabetes
13.5.3. Oncology
13.5.4. Cardiology
13.5.5. Autoimmune Diseases
13.5.6. Nephrology
13.5.7. Drug Testing/Pharmacogenomics
13.5.8. HIV/Aids
13.5.9. Other Applications
13.6. Africa In Vitro Diagnostic Market, By End User
13.6.1. Hospitals
13.6.2. Laboratories
13.6.2.1. Large/Reference Laboratories
13.6.2.2. Medium-Sized Laboratories
13.6.2.3. Small Laboratories
13.6.3. Point-Of-Care Testing
13.6.4. Patient Self-Testing
13.6.5. Academic Institutes
13.6.6. Other End Users
13.7. Africa In Vitro Diagnostic Market Attractiveness Index
13.7.1. By Country
13.7.2. By Product & Services
13.7.3. By Technology
13.7.4. By Application
13.7.5. By End User
14. Recommendation
14.1. Market Strategy
15. Competitive Landscape
15.1. Competition Dashboard
15.2. List and Company Overview of Global Key Players
15.3. Company Profiles
15.3.1. Roche Diagnostics
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product & Services Portfolio
15.3.1.4. Key Developments
15.3.1.5. Business Strategies
15.3.2. Siemens Healthineers
15.3.3. Danaher Corporation
15.3.4. Abbott Laboratories
15.3.5. Thermo Fisher Scientific
15.3.6. Johnson & Johnson
15.3.7. Becton, Dickinson and Company
15.3.8. Bio-Rad Laboratories
15.3.9. Sysmex Corporation
15.3.10. bioMérieux
15.3.11. DiaSorin
15.3.12. Ortho Clinical Diagnostics
15.3.13. Agilent Technologies
15.3.14. QIAGEN
16. Acronyms